Rankings
▼
Calendar
CGEN FY 2018 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena
CGEN
Compugen Ltd.
$215M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$18M
Gross Profit
$17M
94.2% margin
Operating Income
-$23M
-130.5% margin
Net Income
-$23M
-127.0% margin
EPS (Diluted)
$-0.41
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$53M
Total Liabilities
$16M
Stockholders' Equity
$37M
Cash & Equivalents
$46M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$18M
$0
—
Gross Profit
$17M
-$2M
+1152.5%
Operating Income
-$23M
-$37M
+37.9%
Net Income
-$23M
-$37M
+39.0%
← Q4 2017
All Quarters
Q1 2018 →